Panagora Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-4,932
| Closed | -$89K | – | 2910 |
|
|
2020
Q2 | $89K | Sell |
4,932
-13,888
| -74% | -$193K | ﹤0.01% | 1824 |
|
|
2020
Q1 | $134K | Sell |
18,820
-57,208
| -75% | -$714K | ﹤0.01% | 1589 |
|
|
2019
Q4 | $1.82M | Buy |
+76,028
| New | +$2.1M | 0.01% | 822 |
|
|
2018
Q4 | – | Sell |
-6,336
| Closed | -$169K | – | 2579 |
|
|
2018
Q3 | $169K | Hold |
6,336
| – | – | ﹤0.01% | 1731 |
|
|
2018
Q2 | $239K | Sell |
6,336
-46,986
| -88% | -$1.8M | ﹤0.01% | 1601 |
|
|
2018
Q1 | $1.74M | Sell |
53,322
-3,803
| -7% | -$167K | 0.01% | 925 |
|
|
2017
Q4 | $2.78M | Buy |
57,125
+48,588
| +569% | +$2.46M | 0.01% | 743 |
|
|
2017
Q3 | $461K | Buy |
+8,537
| New | +$501K | ﹤0.01% | 1378 |
|
|
2017
Q1 | – | Sell |
-11,594
| Closed | -$260K | – | 2484 |
|
|
2016
Q4 | $260K | Sell |
11,594
-12,433
| -52% | -$243K | ﹤0.01% | 1663 |
|
|
2016
Q3 | $546K | Sell |
24,027
-25,430
| -51% | -$597K | ﹤0.01% | 1417 |
|
|
2016
Q2 | $1.17M | Buy |
49,457
+35,150
| +246% | +$868K | 0.01% | 1061 |
|
|
2016
Q1 | $292K | Buy |
14,307
+14,113
| +7,275% | +$448K | ﹤0.01% | 1519 |
|
|
2015
Q4 | $10K | Sell |
194
-67
| -26% | -$3.25K | ﹤0.01% | 2218 |
|
|
2015
Q3 | $11K | Sell |
261
-201
| -44% | -$9.7K | ﹤0.01% | 2215 |
|
|
2015
Q2 | $21K | Buy |
+462
| New | +$18.6K | ﹤0.01% | 2302 |
|
|
2014
Q3 | – | Sell |
-265
| Closed | -$8K | – | 2394 |
|
|
2014
Q2 | $8K | Hold |
265
| – | – | ﹤0.01% | 2293 |
|
|
2014
Q1 | $7K | Buy |
+265
| New | +$7.07K | ﹤0.01% | 2288 |
|
Panagora Asset Management's PTLA Position: Q3 2020 in Review
Panagora Asset Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 4,932 shares — an estimated $89K sold.
Panagora Asset Management first reported a position in PTLA in Q1 2014 and held it in 17 quarters. The position peaked at $2.78M in Q4 2017. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Panagora Asset Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Panagora Asset Management sold 4,932 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $89K.
- Panagora Asset Management first reported a position in Portola Pharmaceuticals, Inc. in Q1 2014 and held it in 17 quarters.
- Panagora Asset Management's Portola Pharmaceuticals, Inc. position peaked at $2.78M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Panagora Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.